See also this year's filing and all EDGAR filings for this company.
PDF Report 0001631650_2019_Aimmune_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001631650')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001631650, Aimmune Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 312,619,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 26,328,000 |
| 3 | remainder_Assets | 608,000 |
| 4 | LiabilitiesCurrent | 38,012,000 |
| 5 | LiabilitiesNoncurrent | 2,596,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 81,921,000 |
| 9 | ResearchAndDevelopmentExpense | 133,420,000 |
| 10 | remainder_Expenses | 61,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 4,650,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 339,555,000 |
| 1 | Liabilities | 40,608,000 |
| 2 | Expenses | 215,402,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 298,947,000 |
| 5 | NetIncome | -210,752,000 |
| 6 | ComprehensiveNetIncome | -210,752,000 |
| 7 | BaseVar | 300,107,500 |
| 8 | EconomicCapitalRatio | 1.60 |
Edgar->Model Mapping
Feature Distribution
Change over Time
